Mind Medicine (MindMed) Investor Relations Material
Latest events
AGM 2025
Mind Medicine (MindMed)
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Mind Medicine (MindMed) Inc
Access all reports
Mind Medicine (MindMed) Inc is a biopharmaceutical company focused on the development of psychedelic-inspired medicines and therapies for mental health and addiction conditions. The company engages in clinical research and product development targeting various psychiatric and neurological disorders. MindMed operates within the healthcare and biotechnology sectors. The company is headquartered in New York, New York, and its shares are listed on the NASDAQ.
Key slides for Mind Medicine (MindMed) Inc
Q1 2025
Mind Medicine (MindMed) Inc
Q1 2025
Mind Medicine (MindMed) Inc
Latest articles
)
Eli Lilly: The Pharma Giant Behind Mounjaro and Zepbound
Eli Lilly's journey from insulin pioneer to global pharma giant, leading innovation in diabetes, obesity, and the future of metabolic health.
30 Jun 2025
)
500 Years of Craft, One Family Legacy: Beretta Holding's Global Expansion
How Beretta Holding managed to transform from a 16th-century gun barrel producer into a global industrial group while preserving 500 years of legacy.
27 Jun 2025
)
Shuntaro Furukawa: The Sixth President of Nintendo
Shuntaro Furukawa, Nintendo's sixth president, went from a childhood fan to leading the company through global expansion and the launch of Switch 2.
23 Jun 2025
Ticker symbol
MNMD
Country
🇺🇸 United States